The Patent Finder
CH

Chempartner Corporation

First filing 2018
OverviewNotableFeesChangesPatent listSources & methods

0 patents currently held, every record listed here

7 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

This portfolio holds none of the 7 US patents in force on its record. from the record

Of the 7 now held by other companies, 7 name Artios Pharma Limited as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
none
Next term end

When these terms end

Each bar runs from grant to computed term end. 2019 to 2039.
US 10,421,765 TETRAHYDROPYRIDO[4,3-d]PYRIMIDINE INHIBITORS OF ATR KINASE May 25, 2038
US 10,745,420 TETRAHYDROPYRIDO[4,3-d]PYRIMIDINE INHIBITORS OF ATR KINASE May 25, 2038
US 10,392,376 Heterocyclic Inhibitors of Atr Kinase Jul 13, 2038
US 10,800,769 Heterocyclic Inhibitors of Atr Kinase Jul 13, 2038
US 11,434,233 Heterocyclic Inhibitors of Atr Kinase Jul 13, 2038
US 10,800,774 Heterocyclic Inhibitors of Atr Kinase Aug 17, 2038
US 10,894,052 Heterocyclic Inhibitors of Atr Kinase Mar 18, 2039
20232027203120352039
Every computed term in this portfolio is shown above.Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
None of the currently held patents qualifies as notable.

Formerly held, still cited

Notable
The most cited patent in this portfolio, cited by 8 later US patents, top 25% of utility patents granted in 2020 in our data. Protection runs to 2038.
Ends Aug 2038 · High confidence
Also notable
The newest of the three, granted 2020. It anchors the portfolio to 2038, later than anything else here. A terminal disclaimer caps this term to an earlier patent's.
Ends Jul 2038 · High confidence
Also notable
The earliest of the three still in force, granted 2019 and renewed since. Its term ends first, in 2038.
Ends May 2038 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 10, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first.
Also on record: 7 patents in force now held by others. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited